scispace - formally typeset
M

Mary Guardino

Researcher at Nathan Kline Institute for Psychiatric Research

Publications -  12
Citations -  1189

Mary Guardino is an academic researcher from Nathan Kline Institute for Psychiatric Research. The author has contributed to research in topics: Anxiety & Anxiety disorder. The author has an hindex of 11, co-authored 12 publications receiving 1125 citations. Previous affiliations of Mary Guardino include Long Island Jewish Medical Center.

Papers
More filters
Journal ArticleDOI

Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression

TL;DR: Amygdala and nucleus accumbens responses to affective stimuli may reflect vulnerability for major depression, and constraining attention may normalize emotion-related neural function possibly by engagement of the medial prefrontal cortex.
Journal ArticleDOI

Barriers to the treatment of social anxiety.

TL;DR: Social anxiety is associated with a distinct pattern of treatment barriers and treatment access may be improved by building public awareness of locally available services, easing the psychological and financial burden of entering treatment, and increasing health care professionals' awareness of its clinical significance.
Journal ArticleDOI

School-Based Intervention for Adolescents with Social Anxiety Disorder: Results of a Controlled Study

TL;DR: Findings support the possible efficacy of school-based intervention for facilitating access to treatment for socially anxious adolescents.
Journal ArticleDOI

Face-memory and emotion: associations with major depression in children and adolescents

TL;DR: An association between MDD in childhood or adolescence and perturbed encoding of fearful faces may predispose to subtle anomalies in a neural circuit encompassing the amygdala, a brain region implicated in the processing of fearful facial expressions.
Journal ArticleDOI

Response to 5% carbon dioxide in children and adolescents: relationship to panic disorder in parents and anxiety disorders in subjects.

TL;DR: Testing in a family-based design whether CO(2) hypersensitivity is a familial risk marker for PD and associated with current anxiety disorders in children and adolescents found no support was obtained.